Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| CRMD | PRESS-RELEASE | bullish | 7/10 | CorMedix announced that the Federal Circuit affirmed a district court ruling upholding the validity and infringement of | Jun 8, 2026 |
| CWCO | PRESS-RELEASE | neutral | 2/10 | Consolidated Water appointed Sachin Chawla as senior vice president of strategy and growth, a new role focused on busine | Jun 8, 2026 |
| VOR | PRESS-RELEASE | bullish | 7/10 | Vor Biopharma announced that China's NMPA conditionally approved telitacicept for IgA nephropathy, the first BAFF/APRIL- | Jun 8, 2026 |
| AMOD | PRESS-RELEASE | neutral | 4/10 | Alpha Modus completed the conversion of ~3.87M shares of Series C Preferred Stock (90% of outstanding Series C) into com | Jun 8, 2026 |
| HYPD | PRESS-RELEASE | mixed | 6/10 | Hyperion DeFi reported Q1 2026 EPS of $0.26, a 25.7% miss vs the $0.35 consensus, with revenue of $450K. The company rei | Jun 8, 2026 |
| BCDA | PRESS-RELEASE | bearish | 7/10 | BioCardia reported Q1 2026 EPS of -$0.21, missing the consensus estimate of -$0.18 by 16.7%. The company also disclosed | Jun 8, 2026 |
| NCRA | PRESS-RELEASE | neutral | 4/10 | Nocera announced a binding agreement with Digital Innovations Group to form Digital Innovations Venture Group (DIVG), a | Jun 8, 2026 |
| ELAB | PRESS-RELEASE | neutral | 4/10 | PMGC Holdings subsidiary NorthStrive Defense Tech signed a binding term sheet for an exclusive, worldwide, sublicensable | Jun 8, 2026 |
| FCEL | PRESS-RELEASE | bearish | 7/10 | FuelCell Energy reported Q2 2026 revenue of $35.6M, missing the $40.5M consensus, and a GAAP net loss per share of $(1.4 | Jun 8, 2026 |
| LAB | PRESS-RELEASE | mixed | 7/10 | Standard BioTools (LAB) announced a definitive all-stock merger with Treeline Biosciences, a clinical-stage oncology bio | Jun 8, 2026 |
| ACON | PRESS-RELEASE | mixed | 6/10 | Aclarion's Board unanimously rejected Echo Lake Capital's unsolicited $4.00/share acquisition proposal, arguing it signi | Jun 8, 2026 |
| AEC | PRESS-RELEASE | neutral | 3/10 | Anfield Energy provided an operational update on the Shootaring Canyon Uranium Mill reactivation, including completion o | Jun 8, 2026 |
| KYMR | PRESS-RELEASE | bullish | 6/10 | Kymera Therapeutics presented new preclinical data for KT-579, its oral IRF5 degrader, at EULAR and FOCIS meetings, show | Jun 8, 2026 |
| SUNE | PRESS-RELEASE | bullish | 8/10 | SUNation Energy (SUNE) announced a definitive reverse merger agreement with Suniva, the largest U.S.-owned merchant sola | Jun 8, 2026 |
| GNK | PRESS-RELEASE | neutral | 5/10 | Genco Shipping & Trading issued a press release urging shareholders to vote FOR its six director nominees on the WHITE p | Jun 8, 2026 |
| PSN | PRESS-RELEASE | bullish | 6/10 | Parsons Corporation announced its role as engineer of record and prime design consultant for the $721 million I-91/I-691 | Jun 8, 2026 |
| ARTV | PRESS-RELEASE | bullish | 7/10 | Artiva Biotherapeutics presented positive clinical data for AlloNK (AB-101) at EULAR 2026, including a 71% ACR50 respons | Jun 8, 2026 |
| AERT | PRESS-RELEASE | bullish | 6/10 | Aeries Technology reported fiscal year 2026 revenue of $70M (flat YoY), net income of $3.5M vs a $(21.6M) loss last year | Jun 8, 2026 |
| MUX | PRESS-RELEASE | bullish | 7/10 | McEwen Inc. released a Pre-Feasibility Study for its 100%-owned Grey Fox gold project, projecting a 15-year mine life an | Jun 8, 2026 |
| LYEL | PRESS-RELEASE | bullish | 7/10 | Lyell Immunopharma announced updated safety data from its Phase 1 trial of LYL273 in metastatic colorectal cancer, showi | Jun 8, 2026 |
| ABAT | PRESS-RELEASE | bullish | 7/10 | American Battery Technology Company announced the reinstatement of its DOE grant for the $115 million Tonopah Flats Lith | Jun 8, 2026 |
| DLTH | PRESS-RELEASE | bullish | 7/10 | Duluth Trading reported Q1 FY2026 results with a massive EPS beat of $0.23 versus consensus of -$0.39 (159% beat), thoug | Jun 8, 2026 |
| AMD | PRESS-RELEASE | neutral | 4/10 | AMD announced plans to invest up to £2 billion over five years in the UK to accelerate AI innovation, research, and work | Jun 8, 2026 |
| ALVO | PRESS-RELEASE | neutral | 4/10 | Alvotech announced FDA acceptance of its BLA for AVT16, a proposed interchangeable biosimilar to Entyvio (vedolizumab), | Jun 8, 2026 |
| ALVO | PRESS-RELEASE | neutral | 4/10 | Alvotech announced FDA acceptance of its BLA for AVT16, a proposed interchangeable biosimilar to Entyvio (vedolizumab) f | Jun 8, 2026 |
| INGR | PRESS-RELEASE | bullish | 7/10 | Ingredion announced a recommended all-cash offer to acquire Tate & Lyle PLC for approximately £3.7B ($5.0B), representin | Jun 8, 2026 |
| WKEY | PRESS-RELEASE | bullish | 7/10 | WISeKey International Holding Ltd, in collaboration with The Hashgraph Group and Hedera, announced the launch of a QAIT | Jun 8, 2026 |
| NRIX | PRESS-RELEASE | bullish | 8/10 | Nurix Therapeutics announced a global collaboration with Roche to co-develop and co-commercialize bexobrutideg, an oral | Jun 8, 2026 |
| VVY | PRESS-RELEASE | neutral | 1/10 | Vivoryon Therapeutics N.V. announced it will report its Q1 2026 results on June 11, 2026. | Jun 8, 2026 |
| STI | PRESS-RELEASE | bullish | 7/10 | Solidion Technology raised $35M in a private placement priced above market, funding operations through 2028 to commercia | Jun 7, 2026 |